期刊
NATURE BIOTECHNOLOGY
卷 27, 期 11, 页码 987-993出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt1109-987
关键词
-
Despite the global economic slowdown, biologics managed single-digit growth in 2008, driven mainly by continued high growth in sales of antibodies and insulins. Novel biologics in development look promising, but crowding, pricing and reimbursement are emerging as longer-term concerns.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据